Early identification, treatment, and interventions for the prevention of benzodiazepine dependence with anxiety disorders

Mental Health and Substance Use: Dual Diagnosis

Volumn 4, Issue 4, 2011, Pages 277-292

  Blunk, Melanie ^a   Williams, Kimberly ^b  

^a PSC   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

anxiety; benzodiazepine prescribing; unintentional substance dependence

Indexed keywords

BENZODIAZEPINE;

ANXIETY DISORDER; ARTICLE; BLUNK ANXIETY MANAGEMENT PROTOCOL; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITIVE THERAPY; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; HEALTH EDUCATION; HUMAN; INFORMED CONSENT; LONG TERM CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SAFETY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 80053532858     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523281.2011.602642     Document Type: Article

References (24)

1. American Psychiatric Association. (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Retrieved October 29, 2010, from http://www.guideline.gov/content. aspx?id1/45954&search1/4acutestressdisorder
2. American Psychiatric Association. (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. Retrieved October 29, 2010, from http://www.guideline.gov/content.aspx?id1/411078&search1/ 4obsessivecompulsivedisorder
3. American Psychiatric Association. (2009). Practice guideline for the treatment of patients with panic disorder. Retrieved October 29, 2010, from http://www.guideline.gov/content.aspx?id1/414230&search1/4panicdisorder
4. Andlin-Sobocki, P., & Wittchen, H. (2005). Cost of anxiety disorders in Europe. European Journal of Neurology, 12, 39-44. doi: 10.1111/j.1468-1331. 2005.01196.x (Pubitemid 40755602)
5. Ashton, H. (2008). Benzodiazepine dependence. In Web4Health. Retrieved October 29, 2010, from http://web4health.info/en/answers/bio-benzo-dependence. htm
6. TM]. Published instrument. The Psychological Corporation, Harcourt Brace Jovanovich, Inc.
7. Benzo.org.uk. (2007). Benzodiazepine equivalence table. Retrieved October 29, 2011, from http://www.benzo.org.uk/
8. Hunter/New England Area Health Service. (2006). Nurse practitioner clinical practice guidelines for the management of benzodiazepine abuse/dependence. Retrieved October 29, 2011, from Hunter Area Health Service: www.health.nsw.gov.au/resources/nursing/practitioner/pdf/cpg-benzodiazepine.pdf
9. Kenny, P., Swan, A., Berends, L., Jenner, L., Hunter, B., & Mugavin, J. (2009). Alcohol and other drug withdrawal: Practice guidelines 2009. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre.
10. Longo, L., & Johnson, B. (2000). Addiction: Part I. Benzodiazepines - Side effects, abuse risks, and alternatives. American Academy of Family Physicians, 61, 2121-2128. Retrieved October 29, 2010, from http://www.aafp.org/ afp/20000401/2121.html
11. Magellan Health Services. (2008). Magellan clinical practice guidelines for the assessment and treatment of patients with generalized anxiety disorder. Retrieved October 29, 2010, from http://www.magellanprovider.com/MHS/MGL/ providing-care/clinical-guidelines/clin-prac-guidelines/GAD.pdf
12. Maine Benzodiazepine Study Group. (2008). Guidelines for the use of benzodiazepines in office practice in the state of Maine. Retrieved October 29, 2010, from Mainebenzo.org http://www.benzos.une.edu/documents/ prescribingguidelines3-26-08.pdf
13. Mental Health Network. (2009). Clinical practice guidelines: Panic disorder treatment. Retrieved October 29, 2010, from Mental Health Network: https://www.healthnet.com/static/general/unprotected/pdfs/national/policies/ panic-disorder-cpg-may-10.pdf
14. National Institute for Health and Clinical Excellence. (2007). Management for anxiety (panic disorder, with or without agoraphobia, and generalized anxiety disorder) in adults in primary, secondary, community care. Retrieved October 29, 2010, from National Institute for Health and Clinical Excellence: http://www.nice.org.uk/nicemedia/pdf/CG022NICE guidelineamended.pdf
15. National Institute on Drug Abuse. (2008). Magnitude: Drug abuse is costly [Fact sheet]. Retrieved October 29, 2010, from http://www.nida.nih.gov/about/ welcome/aboutdrug abuse/magnitude/
16. National Institute of Mental Health. (2008). The numbers count: Mental disorders in America (Statistics about mental disorders). Retrieved October 29, 2010, from National Institute of Mental Health: http://www.nimh.nih.gov/health/ publications/the-numbers-count-mentaldisorders-in-america/index.shtml#Anxiety
17. Psychiatric Medication Awareness Group. (2001). A strategic plan to address benzodiazepine addiction resulting from prescription practices (Strategic plan). Retrieved October 29, 2010,from Psychiatric Medication Awareness Group: http://www.psychmedaware.org/pdf/BenzodiazepineStrategy.pdf
18. Royal Australian College of General Practitioners. (2000). Guidelines: Benzodiazepines (Guidelines). Retrieved October 29, 2010, from Royal Australian College of General Practitioners: http://www.racgp.org.au/guidelines/ benzodiazepines
19. Sadock, B., & Sadock, V. (2007). Kaplan and Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry (10th ed.). Philadelphia: Lippincot Williams & Wilkins.
20. Sanders, S., Harden, R., & Vincent, P. (2005). Evidence-based clinical practice guidelines for interdisciplinary rehabilitation of chronic non-malignant pain syndrome patients.Retrieved October 29, 2010, from Guideline Central: http://www.guidelinecentral.com/-webapp-1825388/Evidence-based- clinical-practice-guidelines-for-interdisciplinary-rehabilitation-of-chronic- nonmalignant-pain-syndrome-patients
21. Sullivan, E., & Fleming, M. (1997). A guide to substance abuse services for primary care clinicians: Treatment improvement protocol (TIP) series 24. Department of Health and Human Services (DHHS Publication No. (SMA) 97-3139). Rockville, MD: National Clearinghouse for Alcohol and Drug Information.
22. Substance Abuse Mental Health Services Administration. (2005). TIP 43: Medication-assisted treatment for opioid addiction in opioid treatment programs: Treatment improvement protocol (TIP) series 43. Retrieved October 29, 2010, from the National Center for Biotechnology Information: http://www.ncbi.nlm.nih. gov/bookshelf/br.fcgi?book= hssamhsatip&part=A82676
23. Taiwan Food and Drug Administration. (2009). Guidelines for benzodiazepine using in sedation and hypnosis [Newsgroup comment]. Retrieved October 29, 2010, from http://www.fda.gov.tw/files/news/37.doc
24. US Government Accountability Office (GAO). (2009). Medicaid: Fraud and abuse related to controlled substances identified in selected states (GAO-09-957). Washington, DC: US Government Printing Office.